GlaxoSmithKline PLC, which is being sued for allegedly concealing negative information on the effects of its Paxil anti-depressant on children, admitted this week that the drug didn’t show a benefit over a sugar pill when treating depression in children.

Better late than never I suppose… The full list of studies, called for by the medical journal The Lancet is also available from the Glaxo Web site. The Lancet has been an outspoken critic of Glaxo throughout this process.